Inventor · disambiguated record
Arthur F. Kluge
Also filed as: HARRISON IAN T · KLUGE ARTHUR · KLUGE ARTHUR F · KLUGE ARTHUR FREDERICK
96 granted patents·37 pending applications·1,684 citations·filing 1974–2025
99Inventor score
Files withSYNTEX INC23KYMERA THERAPEUTICS INC20CELGENE AVILOMICS RES INC19MITOBRIDGE INC13CELGENE CAR LLC7
Top patents by PatentIndex Score
133 records- 0199US8609679B22,4-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 17, 2013·84 cites·4 claims
- 0298US11723980B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Aug 15, 2023·9 cites·14 claims
- 0398US11117889B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Sep 14, 2021·28 cites·28 claims
- 0498US10874743B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·38 cites·20 claims
- 0598US8710222B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Apr 29, 2014·52 cites·3 claims
- 0698US8450335B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted May 28, 2013·130 cites·22 claims
- 0798US8338439B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted Dec 25, 2012·175 cites·2 claims
- 0898US4255432A8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereofSYNTEX INC·Filed 1979·Granted Mar 10, 1981·95 cites·11 claims
- 0998US4089969A5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereofSYNTEX INC·Filed 1977·Granted May 16, 1978·136 cites·44 claims
- 1097US12258341B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·5 cites·18 claims
- 1197US12168057B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·5 cites·17 claims
- 1297US11807636B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·6 cites·19 claims
- 1397US11292792B2Tricyclic CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·19 cites·15 claims
- 1497US9987276B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jun 5, 2018·23 cites·26 claims
- 1597US4567264ACardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entrySYNTEX INC·Filed 1983·Granted Jan 28, 1986·122 cites·3 claims
- 1696US12006329B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·4 cites·9 claims
- 1796US11512080B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·15 cites·20 claims
- 1896US11352350B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·20 cites·11 claims
- 1996US9212181B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 15, 2015·34 cites·42 claims
- 2096US4232038A5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acidsSYNTEX INC·Filed 1979·Granted Nov 4, 1980·36 cites·19 claims
- 2195US10010548B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jul 3, 2018·15 cites·4 claims
- 2295US9409921B22,4-disubstituted pyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2014·Granted Aug 9, 2016·25 cites·2 claims
- 2395US9296737B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Mar 29, 2016·27 cites·23 claims
- 2495US4087539A5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereofSYNTEX INC·Filed 1977·Granted May 2, 1978·32 cites·39 claims
- 2594US10766888B1HMOX1 inducersMITOBRIDGE INC·Filed 2020·Granted Sep 8, 2020·16 cites·11 claims
- 2694US10399958B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2016·Granted Sep 3, 2019·7 cites·20 claims
- 2794US7989465B24,6-disubstituted pyrimidines useful as kinase inhibitorsAVILA THERAPEUTICS INC·Filed 2009·Granted Aug 2, 2011·26 cites·4 claims
- 2893US8741837B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Jun 3, 2014·10 cites·23 claims
- 2993US8309685B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2009·Granted Nov 13, 2012·20 cites·36 claims
- 3092US11932635B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·1 cites·21 claims
- 3192US9938234B2PPAR agonistsSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Apr 10, 2018·13 cites·10 claims
- 3292US8293705B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted Oct 23, 2012·12 cites·15 claims
- 3392US4244961A1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agentsSYNTEX INC·Filed 1978·Granted Jan 13, 1981·22 cites·32 claims
- 3491US11897882B2Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Feb 13, 2024·1 cites·19 claims
- 3591US10611790B2Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseasesMITOBRIDGE INC·Filed 2016·Granted Apr 7, 2020·11 cites·17 claims
- 3691US10479775B1PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Nov 19, 2019·7 cites·20 claims
- 3790US11351168B12,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2020·Granted Jun 7, 2022·2 cites·3 claims
- 3890US10828300B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Nov 10, 2020·3 cites·27 claims
- 3990US10596172B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Mar 24, 2020·5 cites·3 claims
- 4090US8329901B24,6-disubstitued pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2011·Granted Dec 11, 2012·11 cites·5 claims
- 4190US7982036B24,6-disubstitued pyrimidines useful as kinase inhibitorsAVILA THERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·13 cites·12 claims
- 4290US4097579A5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereofSYNTEX INC·Filed 1977·Granted Jun 27, 1978·33 cites·24 claims
- 4389US11485743B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·6 cites·8 claims
- 4489US8748606B24,6-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Jun 10, 2014·8 cites·4 claims
- 4589US8242271B2Heterocyclic compounds and uses thereofSINGH JUSWINDER·Filed 2008·Granted Aug 14, 2012·9 cites·31 claims
- 4689US4349549AAnti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)sSYNTEX INC·Filed 1981·Granted Sep 14, 1982·37 cites·32 claims
- 4788US8778877B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2008·Granted Jul 15, 2014·10 cites·26 claims
- 4888US8445498B24,6-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2011·Granted May 21, 2013·8 cites·17 claims
- 4987US11578052B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2021·Granted Feb 14, 2023·1 cites·16 claims
- 5087US2025000985A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 133 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Arthur F. Kluge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →